DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis by Henricks, Linda M, PharmD, Lunenburg, Carin A T C, MSc, de Man, Femke M, MD, Meulendijks, Didier, PharmD, Frederix, Geert W J, PhD, Kienhuis, Emma, BSc, Creemers, Geert-Jan, MD, Baars, Arnold, MD, Dezentjé, Vincent O, MD, Imholz, Alexander L T, MD, Jeurissen, Frank J F, MD, Portielje, Johanna E A, Prof, Jansen, Rob L H, MD, Hamberg, Paul, MD, ten Tije, Albert J, MD, Droogendijk, Helga J, MD, Koopman, Miriam, Prof, Nieboer, Peter, MD, van de Poel, Marlène H W, MD, Mandigers, Caroline M P W, MD, Rosing, Hilde, PhD, Beijnen, Jos H, Prof, Werkhoven, Erik van, MSc, van Kuilenburg, André B P, PhD, van Schaik, Ron H N, PhD, Mathijssen, Ron H J, Prof, Swen, Jesse J, PharmD, Gelderblom, Hans, Prof, Cats, Annemieke, MD, Guchelaar, Henk-Jan, Prof, Schellens, Jan H M, Prof

Get full text

The Clinical Implementation of Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry by Jaouad Azzahhafi MD, Wout W. A. van den Broek MD, Dean R. P. P. Chan Pin Yin MD, Ankie M. Harmsze PharmD, PhD, Ron H. N. van Schaik MSc, PhD, Jurriën M. ten Berg MD, PhD

Get full text

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up by Schröder, Fritz H, Prof, Hugosson, Jonas, Prof, Roobol, Monique J, PhD, Tammela, Teuvo L J, Prof, Zappa, Marco, MD, Nelen, Vera, MD, Kwiatkowski, Maciej, MD, Lujan, Marcos, MD, Määttänen, Liisa, PhD, Lilja, Hans, Prof, Denis, Louis J, Prof, Recker, Franz, Prof, Paez, Alvaro, MD, Bangma, Chris H, Prof, Carlsson, Sigrid, MD, Puliti, Donella, MSc, Villers, Arnauld, MD, Rebillard, Xavier, MD, Hakama, Matti, Prof, Stenman, Ulf-Hakan, Prof, Kujala, Paula, MD, Taari, Kimmo, MD, Aus, Gunnar, MD, Huber, Andreas, Prof, van der Kwast, Theo H, Prof, van Schaik, Ron H N, Prof, de Koning, Harry J, Prof, Moss, Sue M, Prof, Auvinen, Anssi, Prof

Get full text

General maternal medication use, folic acid, the MDR1 C3435T polymorphism, and the risk of a child with a congenital heart defect by Obermann-Borst, Sylvia A., MSc, Isaacs, Aaron, PhD, Younes, Zobia, MD, van Schaik, Ron H.N., PhD, van der Heiden, Ilse P., BSc, van Duyn, Cornelia M., PhD, Steegers, Eric A.P., PhD, Steegers-Theunissen, Régine P.M., PhD

Get full text